Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Capital Leases (2016 - 2021)

Historic Capital Leases for Pharma-Bio Serv (PBSV) over the last 12 years, with Q1 2021 value amounting to $52430.0.

  • Pharma-Bio Serv's Capital Leases fell 1836.89% to $52430.0 in Q1 2021 from the same period last year, while for Jan 2021 it was $52430.0, marking a year-over-year decrease of 1836.89%. This contributed to the annual value of $55439.0 for FY2020, which is 1735.27% down from last year.
  • Pharma-Bio Serv's Capital Leases amounted to $52430.0 in Q1 2021, which was down 1836.89% from $55439.0 recorded in Q4 2020.
  • In the past 5 years, Pharma-Bio Serv's Capital Leases registered a high of $72668.0 during Q2 2019, and its lowest value of $20206.0 during Q2 2017.
  • Over the past 5 years, Pharma-Bio Serv's median Capital Leases value was $56397.0 (recorded in 2018), while the average stood at $53923.1.
  • Its Capital Leases has fluctuated over the past 5 years, first skyrocketed by 16211.52% in 2018, then plummeted by 2460.95% in 2019.
  • Quarter analysis of 5 years shows Pharma-Bio Serv's Capital Leases stood at $59795.0 in 2017, then dropped by 23.03% to $46027.0 in 2018, then skyrocketed by 45.74% to $67079.0 in 2019, then decreased by 17.35% to $55439.0 in 2020, then decreased by 5.43% to $52430.0 in 2021.
  • Its last three reported values are $52430.0 in Q1 2021, $55439.0 for Q4 2020, and $58408.0 during Q3 2020.